75 studies found for:    ACRODYSOSTOSIS 2, WITH OR WITHOUT HORMONE RESISTANCE
Show Display Options
Rank Status Study
1 Recruiting Reversing Hormone Resistance in Advanced Breast Cancer With Pazopanib
Conditions: Breast Cancer;   Breast Neoplasm
Intervention: Drug: Pazopanib
2 Recruiting Evaluation of Patients With Thyroid Disorders
Conditions: Hyperthyroidism;   Hypothyroidism;   Pituitary Neoplasm
Intervention:
3 Recruiting Substrate Metabolism and Insulin Sensitivity in Acromegalic Patients Before and After Treatment
Conditions: Acromegaly;   Growth Hormone;   Insulin Resistance
Intervention: Procedure: Transsphenoidal adenomectomy
4 Completed
Has Results
Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance
Conditions: HIV-Associated Lipodystrophy Syndrome;   Insulin Resistance;   HIV Infections;   Metabolic Syndrome X;   Body Weight Changes
Interventions: Drug: Rosiglitazone;   Drug: Recombinant human growth hormone + rosiglitazone
5 Recruiting Role of Growth Hormone Antagonism in Modulating Insulin Sensitivity in Subjects With Pre-diabetes
Conditions: Diabetes;   Metabolic Syndrome;   Insulin Resistance
Intervention: Drug: pegvisomant
6 Completed Effect of Growth Hormone on Insulin Signaling in Muscle Tissue
Condition: Insulin Resistance
Intervention: Device: Physiological Bolus of Growth Hormone
7 Unknown  Study to Examine Insulin Resistance During Growth Hormone Treatment for Short Stature Due to Low Birthweight
Condition: Fetal Growth Retardation
Intervention: Drug: somatropin (rDNA)
8 Terminated Study to Identify Markers of Insulin Resistance During Growth Hormone Treatment for Short Stature
Conditions: Turner Syndrome;   Idiopathic Short Stature
Intervention: Drug: somatropin (rDNA)
9 Active, not recruiting Gut Hormone Response After Paleolithic-type Meals
Conditions: Insulin Resistance;   Satiety
Interventions: Other: PAL-2;   Other: TFH-1;   Other: Reference
10 Completed The Effects of TZD on Fat Metabolism and Insulin Sensitivity in GH-Replaced GHD Patients
Condition: Growth Hormone Deficiency
Intervention: Drug: Pioglitazone
11 Recruiting Resistance to Vitamin D or Parathyroid Hormone
Conditions: Hypocalcemia;   Osteomalacia;   Pseudohypoparathyroidism;   Pseudo-Pseudohypoparathyroidism;   Rickets
Intervention:
12 Active, not recruiting Study of BMS-754807 Combined With Letrozole or BMS-754807 Alone in Patients With Hormone Receptor-Positive Breast Cancer and Resistance to Non-Steroidal Aromatase Inhibitors
Condition: Breast Cancer
Interventions: Drug: BMS-754807;   Drug: letrozole
13 Completed Pioglitazone Treatment in Polycystic Ovary Syndrome
Condition: Polycystic Ovary Syndrome
Intervention: Drug: pioglitazone
14 Recruiting T-IR- Study to Understand the Effects of Testosterone and Estrogen on the Body's Response to the Hormone Insulin, Which Regulates Blood Sugar Levels
Conditions: Insulin Resistance;   Type 2 Diabetes Mellitus;   Obesity;   Androgen Deficiency;   Metabolic Disease
Interventions: Drug: Acyline;   Drug: Testosterone 1.62% gel;   Drug: Letrozole;   Drug: Placebo gel (for Testosterone 1.62% gel);   Drug: Placebo pill (for Letrozole)
15 Completed Growth Hormone and Glucose Metabolism
Condition: Growth Hormone Deficiency
Intervention: Drug: recombinant human Growth Hormone (Genotropin® )
16 Completed The Effects of Growth Hormone (GH) on Lipid Depots
Condition: Growth Hormone Deficiency
Intervention: Drug: Growth hormone replacement therapy in growth hormone deficient patients only.
17 Completed Insulin Sensitivity and Substrate Metabolism Before and After Treatment in Patients With Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
Intervention: Drug: growth hormone (genotropin)
18 Completed Low Dose Growth Hormone (GH) on Insulin Sensitivity and Cortisol Production Rates
Condition: Growth Hormone Deficiency
Interventions: Drug: Growth hormone (Genotropin);   Drug: Placebo
19 Recruiting Hormone Blockade in Combination With Targeted Agents
Conditions: Solid Tumors;   Advanced Cancer
Interventions: Drug: Anastrozole;   Drug: Bevacizumab;   Drug: Everolimus;   Drug: Sorafenib;   Drug: Erlotinib
20 Unknown  The Vascular Effects of Vildagliptin in Insulin Resistant Individuals
Conditions: Insulin Resistance;   Microvascular Disease
Interventions: Drug: Vildagliptin;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years